Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation.
Teraoka S, Ota K, Tanabe K, Takahashi K, Toma H, Yasumura T, Yoshimura N, Oka T, Takahara S, Okuyama A, Haba T, Uchida K, Sugiyama S, Ohshima S, Sato T, Okazaki H, Morozumi K.
Teraoka S, et al. Among authors: yoshimura n.
Transplant Proc. 1997 Feb-Mar;29(1-2):266-71. doi: 10.1016/s0041-1345(96)00633-1.
Transplant Proc. 1997.
PMID: 9122990
Clinical Trial.
No abstract available.